NCT01355705 2018-09-18Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple MyelomaStanford UniversityPhase 1/2 Completed14 enrolled 9 charts